Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Purchase | 2024-02-06 10:27 am | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 33,333 | $0.3 | $10,000 | 224,313 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-08 Option Award | 2024-04-10 9:52 pm | N/A 2034-04-08 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 35,000 | $0 | 276,688 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-06 10:27 am | 2024-02-01 2029-02-01 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 66,666 | $0 | 224,313 (Direct) | View |
| 2023-09-21 Option Award(A) | 2023-10-12 6:01 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 39,475 | $0 | 45,428 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 6:24 pm | N/A 2033-09-22 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 68,961 | $0 | 74,914 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-09 2:34 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 3,750 | $0.268 | 3,750 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 5:00 pm | N/A 2031-07-15 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 32,000 | $0 | 178,559 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 5:23 pm | N/A 2030-06-12 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 46,559 | $0 | 146,559 (Direct) | View |